BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29550399)

  • 1. Silica based hybrid materials for drug delivery and bioimaging.
    Bagheri E; Ansari L; Abnous K; Taghdisi SM; Charbgoo F; Ramezani M; Alibolandi M
    J Control Release; 2018 May; 277():57-76. PubMed ID: 29550399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bioimaging Applications of Mesoporous Silica Nanoparticles.
    Pratiwi FW; Kuo CW; Wu SH; Chen YP; Mou CY; Chen P
    Enzymes; 2018; 43():123-153. PubMed ID: 30244805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organosilica Nanoparticles and Medical Imaging.
    Nakamura M
    Enzymes; 2018; 44():137-173. PubMed ID: 30360813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
    Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
    Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles.
    Haque ST; Chowdhury EH
    Curr Drug Deliv; 2018; 15(4):485-496. PubMed ID: 29165073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
    Croissant JG; Fatieiev Y; Almalik A; Khashab NM
    Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in multifunctional silica-based hybrid nanocarriers for bioimaging and cancer therapy.
    Lim WQ; Phua SZ; Xu HV; Sreejith S; Zhao Y
    Nanoscale; 2016 Jul; 8(25):12510-9. PubMed ID: 26750573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.
    Liu Y; Lou C; Yang H; Shi M; Miyoshi H
    Curr Cancer Drug Targets; 2011 Feb; 11(2):156-63. PubMed ID: 21158720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
    Rosenholm JM; Sahlgren C; Lindén M
    Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.